Early metabolic responses in temozolomide treated low-grade glioma patients. - Wikidata - wikimedia - TriplyDB

Early metabolic responses in temozolomide treated low-grade glioma patients.

Early metabolic responses in temozolomide treated low-grade glioma patients.

http://www.wikidata.org/entity/Q46043349

about

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.PET imaging of gliomas using novel tracers: a sleeping beauty waiting to be kissed.Current treatment of low grade gliomas From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?Promise and pitfalls of quantitative imaging in oncology clinical trials.Amino acid positron emission tomography to monitor chemotherapy response and predict seizure control and progression-free survival in WHO grade II gliomas Discriminant analysis of ¹⁸F-fluorothymidine kinetic parameters to predict survival in patients with recurrent high-grade glioma.Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity.18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?Amino acid PET and MR perfusion imaging in brain tumours.Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.(18)F-FET and (18)F-FCH uptake in human glioblastoma T98G cell lines.Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.Usefulness of positron emission tomographic studies for gliomas.Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?The Clinical Value of PET with Amino Acid Tracers for Gliomas WHO Grade II Static and dynamic 18F-FET PET for the characterization of gliomas defined by IDH and 1p/19q status.Comparison of 18F-FET PET and perfusion-weighted MRI for glioma grading: a hybrid PET/MR study.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.Imaging practice in low-grade gliomas among European specialized centers and proposal for a minimum core of imaging

P2860

Q26853308-5FC9AB2B-1C86-4F31-B314-5A28D184A1CA Q26853516-E8C1345F-89CF-4D0A-B0B8-5085FB77589E Q30967370-F9D34222-80B8-4026-9E6D-47FEF1544B59 Q31156299-E19CD91C-09E0-48AF-9333-42329F1BACDF Q33578187-1BDFED72-BEF7-4480-BCB0-2707DA5931B3 Q34830708-E52757E3-9065-432F-86B8-1ED6B3FE865A Q35679377-27DEF15F-34F7-4090-92B3-7000F3C8CDC7 Q36303765-40657C76-68C5-4782-B008-1180675DBC17 Q36785136-F48C9983-3DB4-475D-9D47-215EE253ACF3 Q37323697-254B08A6-A5CA-4F1B-92E9-2FDFA57C2ADA Q37900207-42A99CDB-0A57-4F0E-B6A0-16983E01A054 Q38403271-5BD79C3E-7A28-4B1D-A163-EAD6A02D5693 Q38691946-CCA539CF-94E3-496E-A4FC-C8DEA2B913A1 Q38815396-D9871699-7B01-4518-A9CF-F1C39960F9A2 Q39719750-00025130-C442-414C-B45C-D6C095BC58B7 Q41594601-E92735FA-2C70-471A-9BB4-5DE2CBB70350 Q41965733-EABF6E00-7D2E-41BF-B1AC-161AE0FDA061 Q42234940-8DCF6A7B-3188-4944-AB75-B3976B76F481 Q42734117-CB625EC3-0806-4086-85EA-5CD6E8BD957F Q47771695-0FDB259A-61D2-4ECE-9348-F3CDF189C4BC Q48143872-156356BC-3665-46BD-9BA2-054D4C378CC4 Q48158155-FBBBD1DC-ADF9-460D-ADA3-2E1AD90174EF Q48341481-3ED9FE27-B01D-4D0D-81E1-4B46AEE320ED Q57176630-F4D389E7-C81C-48EF-B2C0-001987832BE2

P2860

Early metabolic responses in temozolomide treated low-grade glioma patients.

http://www.wikidata.org/entity/Q46043349

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Early metabolic responses in temozolomide treated low-grade glioma patients.

@en

Early metabolic responses in temozolomide treated low-grade glioma patients.

@nl

type

label

Early metabolic responses in temozolomide treated low-grade glioma patients.

@en

Early metabolic responses in temozolomide treated low-grade glioma patients.

@nl

prefLabel

Early metabolic responses in temozolomide treated low-grade glioma patients.

@en

Early metabolic responses in temozolomide treated low-grade glioma patients.

@nl

P1433

Q46043349-A809128E-A316-4720-861E-EBD16E6C7EDB

P1476

Q46043349-C214ED93-C443-4F46-8E6D-C17AA059FFD3

P2093

Q46043349-10773268-E845-4505-8631-4E84F01DF225

Q46043349-56921B32-E557-4AF0-917E-D79BE21DF3CD

Q46043349-868C8457-0F39-46B1-96EB-D14AD113F8E5

Q46043349-9862BCFE-1E34-48DF-9B94-DFDA167EAD58

Q46043349-9BB298E8-5C43-4B5F-9E92-6A3F3F0DF792

Q46043349-A64DA63F-C2A2-459F-BF82-2AB422A0B981

Q46043349-E2961F2B-F90F-41BD-93F7-950074F1D503

Q46043349-EB20DA22-880B-4AB2-87A7-728A3CD32ED1

P2860

Q46043349-00DE2D44-BE8A-41ED-8B98-AD8D52E6B7AA

Q46043349-0737057D-42CA-404C-82E8-4F634CAE6F3C

Q46043349-09065705-3979-46C3-B1D8-B5DA67A4CFCC

Q46043349-0FD7A9BD-AC9A-46DF-BE88-0C0B737029A6

Q46043349-1DF478EB-75D9-49A2-892C-23BE6905421A

Q46043349-31C34652-1DA3-4A79-AACC-286F6BC93EF4

Q46043349-344CF4FD-A5A0-498E-8BBD-39CDFEC71AE3

Q46043349-3899174A-0CF6-4976-8A31-92160726064B

Q46043349-3A1E06FF-5329-4768-B6BB-BABDA646CD34

Q46043349-47743DAE-1B68-49E1-A573-E0D73E5DC02E

P2888

Q46043349-B6734D49-08E6-42BE-A911-0C5EF8D45AA3

P304

Q46043349-02B1AEC5-6B6C-42CC-8627-0C5BD61EED60

P31

Q46043349-A88E1B4B-DE37-4E62-B17F-9D45D0506CB1

P356

Q46043349-9427D9B3-B91E-4F50-9156-DA32CBDAD985

P433

Q46043349-8259E486-C5EC-4C8F-A6A9-C725363A1A5C

P478

Q46043349-DC730AF7-15BC-44B1-B2BC-67DE8BF62BF0

P577

Q46043349-7C5CE4B4-A923-4B6F-A9AE-3008FEDF2F10

P5875

Q46043349-1D7DF6AC-C33E-49D6-81C3-80A0589896E7

P698

Q46043349-DCE39B6D-918F-4CC8-BBDD-B746F94BE600

P356

S11060-009-9896-2

P1433

Journal of Neuro-Oncology

P1476

Early metabolic responses in temozolomide treated low-grade glioma patients.

@en

P2093

Catrina Uhlmann

http://www.w3.org/2001/XMLSchema#string

Esther Bärtschi

http://www.w3.org/2001/XMLSchema#string

Martin Hefti

http://www.w3.org/2001/XMLSchema#string

Matthias Bruehlmeier

http://www.w3.org/2001/XMLSchema#string

Matthias Wyss

http://www.w3.org/2001/XMLSchema#string

Silvia Hofer

http://www.w3.org/2001/XMLSchema#string

Ulrich Roelcke

http://www.w3.org/2001/XMLSchema#string

Ulrich Wolf Buettner

http://www.w3.org/2001/XMLSchema#string

P2860

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.

Outcome in adult low-grade glioma: the impact of prognostic factors and treatment.

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions.

Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome.

A JAVA environment for medical image data analysis: initial application for brain PET quantitation.

Spatial heterogeneity of low-grade gliomas at the capillary level: a PET study on tumor blood flow and amino acid uptake.

Predictive and prognostic markers in neuro-oncology.

Phase II trial of temozolomide in patients with progressive low-grade glioma.

The WHO classification of tumors of the nervous system.

L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.

P2888

s11060-009-9896-2

P304

87-93

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-009-9896-2

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2009-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24312272

http://www.w3.org/2001/XMLSchema#string

P698

19381442

http://www.w3.org/2001/XMLSchema#string